1. Home
  2. ZGM vs HOWL Comparison

ZGM vs HOWL Comparison

Compare ZGM & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ZGM

Zenta Group Company Limited Ordinary Shares

N/A

Current Price

$2.12

Market Cap

26.6M

ML Signal

N/A

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.70

Market Cap

29.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZGM
HOWL
Founded
2019
2017
Country
Macau
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.6M
29.7M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
ZGM
HOWL
Price
$2.12
$0.70
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$7.00
AVG Volume (30 Days)
16.6K
485.7K
Earning Date
01-06-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
24.81
N/A
EPS
0.10
N/A
Revenue
$3,163,046.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$21.44
N/A
Revenue Growth
55.90
N/A
52 Week Low
$1.90
$0.53
52 Week High
$4.51
$2.38

Technical Indicators

Market Signals
Indicator
ZGM
HOWL
Relative Strength Index (RSI) 42.31 52.66
Support Level $2.00 $0.59
Resistance Level $2.30 $0.73
Average True Range (ATR) 0.26 0.07
MACD -0.04 0.01
Stochastic Oscillator 15.00 52.38

Price Performance

Historical Comparison
ZGM
HOWL

About ZGM Zenta Group Company Limited Ordinary Shares

Zenta Group Co Ltd is a professional services provider in Macau, offering industrial park consulting services, business investment consulting services through LIC, and the sale of fintech products and services through LFT. Its industrial park consulting services focus on the pre-development stage, assisting with applications and negotiations for industrial park projects with PRC government authorities, with plans to expand into post-development services through LMS. The business investment consulting services mainly involve assisting clients in acquiring equity stakes in technology firms, private equity management firms, and industrial park project firms, supported by third-party professionals. The Group operates in Macau and the PRC, generating the majority of its revenue from the PRC.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Share on Social Networks: